Patent Application Titled "Multispecific Binding Moieties Comprising Pd-1 And Tgf-Brii Binding Domains" Published Online (USPTO 20230159645).

Předmět:
Zdroj: Cancer Vaccine Week; 6/12/2023, p157-157, 1p
Abstrakt: "The present disclosure provides a multispecific binding moiety comprising a PD-1 binding domain and a TGF-bRII binding domain, wherein the PD-1 binding domain blocks PD-1 mediated signaling and the TGF-bRII binding domain blocks TGF-bRII-mediated signaling. A multispecific binding moiety comprising a PD-1 binding domain and a TGF-bRII binding domain, wherein the PD-1 binding domain blocks PD-1 mediated signaling and the TGF-bRII binding domain blocks TGF-bRII-mediated signaling. "The present disclosure also provides a multispecific binding moiety comprising a PD-1 binding domain and a TGF-bRII binding domain, wherein the TGF-bRII binding domain comprises a heavy chain variable region comprising CDR1, CDR2, and CDR3 sequences as described further herein. [Extracted from the article]
Databáze: Complementary Index